Seeyond’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$309K Sell
1,164
-1,657
-59% -$404K 0.03% 471
2022
Q3
$528K Sell
2,821
-742
-21% -$159K 0.06% 412
2022
Q2
$715K Sell
3,563
-72
-2% -$16.9K 0.08% 378
2022
Q1
$1.1M Buy
3,635
+1,568
+76% +$458K 0.11% 317
2021
Q4
$742K Hold
2,067
0.07% 417
2021
Q3
$684K Sell
2,067
-3,504
-63% -$1.18M 0.07% 419
2021
Q2
$1.71M Sell
5,571
-177
-3% -$49.7K 0.16% 213
2021
Q1
$1.42M Buy
5,748
+114
+2% +$28.7K 0.14% 237
2020
Q4
$1.54M Sell
5,634
-504
-8% -$125K 0.16% 217
2020
Q3
$1.45M Buy
6,138
+48
+0.8% +$10.8K 0.16% 200
2020
Q2
$1.16M Buy
6,090
+1,602
+36% +$287K 0.13% 234
2020
Q1
$1.2M Sell
4,488
-2,223
-33% -$407K 0.17% 169
2019
Q4
$1.32M Sell
6,711
-483
-7% -$90.4K 0.14% 262
2019
Q3
$1.29M Sell
7,194
-315
-4% -$54.5K 0.13% 264
2019
Q2
$1.31M Sell
7,509
-258
-3% -$44.2K 0.14% 248
2019
Q1
$1.48M Buy
7,767
+2,241
+41% +$398K 0.14% 240
2018
Q4
$882K Buy
+5,526
New +$936K 0.12% 260

Other funds holding ISRG

Seeyond's ISRG Position: Q4 2022 in Review

Seeyond reduced its Intuitive Surgical (ISRG) stake by 59% in Q4 2022, selling an estimated $404K and leaving 1,164 shares worth $309K. The position accounts for 0.03% of the portfolio, ranked #471.

Seeyond first reported a position in ISRG in Q4 2018 and has held it in 17 quarters since. The position peaked at $1.71M in Q2 2021. 1,437 funds tracked by Wall St. Rank hold ISRG as of Q4 2022.

  • Seeyond held 1,164 shares of Intuitive Surgical worth $309K as of Q4 2022.
  • Seeyond sold 1,657 Intuitive Surgical shares in Q4 2022, an estimated $404K.
  • Intuitive Surgical made up 0.03% of Seeyond's portfolio in Q4 2022, its #471 holding.
  • Seeyond first reported a position in Intuitive Surgical in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's Intuitive Surgical position peaked at $1.71M in Q2 2021.
  • 1,437 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.